303 related articles for article (PubMed ID: 32375658)
1. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
[TBL] [Abstract][Full Text] [Related]
3. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
Stecher CW; Fofana HKM; Madsen H; Wilson S; Keita AD; Landouré A; Traoré MS; Vennervald BJ; Reimert CM; Sacko M
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):316-324. PubMed ID: 29165707
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.
Dejon-Agobé JC; Edoa JR; Honkpehedji YJ; Zinsou JF; Adégbitè BR; Ngwese MM; Mangaboula A; Lell B; Woldearegai TG; Grobusch MP; Mordmüller B; Adegnika AA
Parasit Vectors; 2019 Dec; 12(1):577. PubMed ID: 31823806
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of praziquantel drug against Schistosoma haematobium and performance of urine reagent strips among pre-and-school aged children during the high transmission season in North-Western Tanzania.
Mazigo HD; Kayange N; Ambrose EE; Zinga MM; Mugassa S; Ruganuza D; Mwingira UJ; Uisso C; Mutapi F
Acta Trop; 2024 Aug; 256():107232. PubMed ID: 38729329
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
Mutapi F; Rujeni N; Bourke C; Mitchell K; Appleby L; Nausch N; Midzi N; Mduluza T
PLoS Negl Trop Dis; 2011 May; 5(5):e1143. PubMed ID: 21610855
[TBL] [Abstract][Full Text] [Related]
7. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
11. [Dynamics of Egg Excretion of
Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
[TBL] [Abstract][Full Text] [Related]
12. Comparison of praziquantel efficacy at 40 mg/kg and 60 mg/kg in treating Schistosoma haematobium infection among schoolchildren in the Ingwavuma area, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Mukaratirwa S
S Afr Med J; 2020 Jul; 110(7):657-660. PubMed ID: 32880343
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of praziquantel against Schistosoma haematobium infection in children.
Tchuenté LA; Shaw DJ; Polla L; Cioli D; Vercruysse J
Am J Trop Med Hyg; 2004 Dec; 71(6):778-82. PubMed ID: 15642971
[TBL] [Abstract][Full Text] [Related]
15. Predicting the timing of second praziquantel treatment and its effect on reduction of egg counts in southern Ghana.
Nsowah-Nuamah NN; Aryeetey ME; Jolayemi ET; Wagatsuma Y; Mensah G; Dontwi IK; Nkrumah FK; Kojima S
Acta Trop; 2004 May; 90(3):263-70. PubMed ID: 15099813
[TBL] [Abstract][Full Text] [Related]
16. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
Ben SA; Useh MF
Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
[TBL] [Abstract][Full Text] [Related]
18. Effect of praziquantel on the immature stages of Schistosoma haematobium.
Botros S; Pica-Mattoccia L; William S; El-Lakkani N; Cioli D
Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review.
Kabuyaya M; Chimbari MJ; Mukaratirwa S
Infect Dis Poverty; 2018 Jul; 7(1):73. PubMed ID: 29986763
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
